Cargando…

Sirolimus in lymphangioleiomyomatosis: A case in point for research in ‘orphan’ diseases

Detalles Bibliográficos
Autores principales:	Koul, Parvaiz A, Mehfooz, Nazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625251/ https://www.ncbi.nlm.nih.gov/pubmed/31290424 http://dx.doi.org/10.4103/lungindia.lungindia_280_19

Ejemplares similares

Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis
por: Aghaeimeybodi, Fatemeh, et al.
Publicado: (2019)

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)

Unexpected sirolimus-stimulated airway hyperreactivity in lymphangioleiomyomatosis
por: Steagall, Wendy K., et al.
Publicado: (2023)

Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
por: Neurohr, Claus, et al.
Publicado: (2011)

Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis
por: Hu, Siqi, et al.
Publicado: (2019)

Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study
por: Zhan, Yongzhong, et al.
Publicado: (2018)

Pulmonary lymphangioleiomyomatosis presenting as spontaneous pneumothorax treated with sirolimus - A case report
por: Verma, Ajay Kumar, et al.
Publicado: (2018)

Efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis: a case series
por: Zhou, Li, et al.
Publicado: (2018)

Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis
por: Namba, Masashi, et al.
Publicado: (2017)

Successful treatment of a patient with chyluria due to lymphangioleiomyomatosis using sirolimus
por: Sakaue, Takahiko, et al.
Publicado: (2018)

Successful Sirolimus Treatment of Lymphangioleiomyomatosis in a Hepatitis B Virus Carrier
por: Sonobe, Shoko, et al.
Publicado: (2018)

Quantitative analysis of computed tomography of the lungs in patients with lymphangioleiomyomatosis treated with sirolimus
por: Ko, Yuki, et al.
Publicado: (2020)

Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations
por: Freitas, Carolina Salim Gonçalves, et al.
Publicado: (2015)

Sirolimus Suppresses Phosphorylation of Cofilin and Reduces Interstitial Septal Thickness in Sporadic Lymphangioleiomyomatosis
por: Huang, Yen-Lin, et al.
Publicado: (2021)

Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort
por: Gopalakrishnan, Vissagan, et al.
Publicado: (2018)

Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience
por: Revilla-López, Eva, et al.
Publicado: (2021)

Effective communication, the heart of the art of medicine
por: Koul, Parvaiz A
Publicado: (2017)

Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: a historical prospective self-controlled study
por: Cheng, Chongsheng, et al.
Publicado: (2022)

Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis
por: Sakurai, Teiko, et al.
Publicado: (2021)

Spirometric abnormalities in patients with sleep-related breathing disorders
por: Mehfooz, Nazia, et al.
Publicado: (2021)

Good educators and orphans: the case of direct observation and feedback
por: Rietmeijer, Chris BT, et al.
Publicado: (2019)

Sporadic Lymphangioleiomyomatosis Disease: A Case Report
por: Nikmanesh, Yousef, et al.
Publicado: (2023)

Patients with rare diseases: from therapeutic orphans to pioneers of personalized treatments
por: Klein, Christoph, et al.
Publicado: (2017)

Pulmonary function testing during the COVID-19 pandemicin
por: Christopher, Devasahayam Jesudas, et al.
Publicado: (2021)

Prevalence and predictors of pulmonary embolism in patients with acute exacerbation of chronic obstructive pulmonary disease
por: Chaudhary, Nasir, et al.
Publicado: (2021)

Commentary: Pseudoxanthoma elasticum: An orphan disease with important implications for cardiothoracic surgeons
por: Gottardi, Roman
Publicado: (2021)

Management of lymphangioleiomyomatosis
por: Taveira-DaSilva, Angelo M., et al.
Publicado: (2014)

Lymphangioleiomyomatosis (LAM)
Publicado: (2017)

The orphan child: humanities in modern medical education
por: Kollmer Horton, Mary E.
Publicado: (2019)

An “Orphan” in search of a treatment: Pulmonary alveolar microlithiasis
por: Tendolkar, Manjit Sharad
Publicado: (2019)

Success has many fathers, failure remains an orphan
por: Bonneux, Luc
Publicado: (2011)

Challenges in linking health research to policy: a commentary on developing a multi-stakeholder response to orphans and vulnerable children in Ghana
por: Gyapong, John Owusu, et al.
Publicado: (2011)

Treatment of lymphangioleiomyomatosis and Camões
por: Rufino, Rogério
Publicado: (2015)

Methylprednisolone in the treatment of lymphangioleiomyomatosis
por: Dale, Ventour, et al.
Publicado: (2022)

Chylothorax, in the Spotlight of Lymphangioleiomyomatosis
por: Gámez-Baeza, Pablo, et al.
Publicado: (2022)

Lymphangioleiomyomatosis: A Case Report and Review of Literature
por: Rhee, Jee Ah, et al.
Publicado: (2019)

Primary abdominal lymphangioleiomyomatosis: report of a case
por: Ding, Yuan, et al.
Publicado: (2015)

Lymphangioleiomyomatosis: an explosive presentation of a rare disease
por: Pais, Faye, et al.
Publicado: (2017)

Pointing to the Future of Language Research
por: Long, Michael, et al.
Publicado: (2021)

Pulmonary lymphangioleiomyomatosis in a male.
por: Kang, H. W., et al.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_pq4fp2gaflrei9clovjt4q5qg0